Parkinson's Neuroprotection 2025: Three Strategies Under Review
Stem cell therapy, System Xc- pathway modulation, and Ayurvedic add-on regimens are each being evaluated as neuroprotective strategies in Parkinson's disease.
Highlights
Health Literacy and Lung Cancer Diagnostic Delays
Patients with limited health literacy experience significant delays in lung cancer diagnosis. This ultimately exacerbates existing health inequities and burdens the healthcare system.
ctDNA Liquid Biopsy in Colorectal Cancer: Where the Evidence Sits Now
Three 2026 reviews map the current evidence for ctDNA and liquid biopsy in CRC detection and monitoring, and where integration lags behind the data.
SGLT2 Inhibitors Post-Heart Transplant: What the Data Show
A 2026 meta-analysis examines SGLT2 inhibitor use in diabetic heart transplant recipients, a population where evidence has been thin and stakes are high.
PCSK9 Inhibitors Move Upstream: Evolocumab Tested in Diabetes Without Known Atherosclerosis
VESALIUS-CV tests evolocumab in diabetic patients without established atherosclerosis, while new trials probe plaque biology and lipid pathways beyond LDL.
News
Endocrinology|Can Routine CT Scans Predict Osteoporosis Risk?Endocrinology|Lorlatinib and New-Onset Diabetes Practical Monitoring for OncologistsEndocrinology|SGLT2 Inhibitors: Promise and Peril in Prader-Willi Syndrome?Critical Care|ECPR Rewarming: A Case for Prolonged Resuscitation?Psychiatry|Addiction Recovery: A Canadian Perspective on a Global CrisisEndocrinology|SGLT2 Inhibitors in Prader-Willi Syndrome: Weighing Renal RisksNeurology|Parkinson's Neuroprotection 2025: Three Strategies Under ReviewHepatology|Do Condition-Specific Growth Charts Improve Care in Alagille Syndrome?Cardiology|Atrial Fibrillation Complexity: How Reliable is Registry Data?Immunology|Improving PID Diagnosis with Machine Learning Phenotype ProfilingHepatology|Alagille Syndrome Growth Charts Improve Patient CareEndocrinology|Unraveling MASH: Implications for Clinical PracticeEndocrinology|Can Routine CT Scans Predict Osteoporosis Risk?Endocrinology|Lorlatinib and New-Onset Diabetes Practical Monitoring for OncologistsEndocrinology|SGLT2 Inhibitors: Promise and Peril in Prader-Willi Syndrome?Critical Care|ECPR Rewarming: A Case for Prolonged Resuscitation?Psychiatry|Addiction Recovery: A Canadian Perspective on a Global CrisisEndocrinology|SGLT2 Inhibitors in Prader-Willi Syndrome: Weighing Renal RisksNeurology|Parkinson's Neuroprotection 2025: Three Strategies Under ReviewHepatology|Do Condition-Specific Growth Charts Improve Care in Alagille Syndrome?Cardiology|Atrial Fibrillation Complexity: How Reliable is Registry Data?Immunology|Improving PID Diagnosis with Machine Learning Phenotype ProfilingHepatology|Alagille Syndrome Growth Charts Improve Patient CareEndocrinology|Unraveling MASH: Implications for Clinical Practice